PACS Group is trading 4.06% down at $42.74 as investors sell equities broadly amid rising Treasury yields, elevated oil prices, and caution before the September 16 Federal Reserve decision.
- The broader market is weaker, while healthcare is outperforming, suggesting macro risk-off pressure rather than sector weakness.
- PACS Group announced a September 15 Jefferies healthcare conference presentation; no company-specific negative announcement was identified.